A director of an energy company who was kicked off the board of directors for missing too many meetings has lost a Federal Court challenge to his dismissal.
Liquidators for failed engineering services company Hastie Group have a fight on their hands over tens of millions of dollars in unpaid invoices from construction companies, with major builders claiming not only that they don’t have to pay, but that the bills aren’t payable.
A judge has granted Cargill Australia’s request to call a King & Wood Mallesons solicitor that represented Viterra as a witness in the epic trial over the $420 million sale of Viterra’s Joe White business to Cargill in 2013.
Viterra is blaming several former employees for representations made about malt quality in the lead-up to the $420 million sale of its Joe White business to Cargill Australia in 2013.
The lead applicant in an investor class action against Fitch Ratings will get its hands on internal reports detailing why the agency assigned a Triple A rating to Sigma Finance Corporation ahead of its 2008 collapse, and whether it could have predicted the fall of the $27 billion investment fund.
The firm running the class action against Fitch Ratings over SCDO products has been given the go ahead to add claims of fraud and deceit after lawyers allegedly unearthed a hidden mathematical table the agency used in assigning ratings to the toxic financial products.
Facing cross-examination over the law firm’s bid to add fraud and deceit claims to a class action against Fitch Ratings, a Squire Patton Boggs lawyer exchanged fire with a barrister for the ratings agency, saying Fitch was having a regular “whinge” about discovery and “no” she would not take the comment back.
A thorny dispute between Norton Rose Fulbright and former employment partner Thomas Martin will head to trial after the Federal Court heard Monday that “all attempts at mediation have failed”.
A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.